C. Frank Bennett, EVP, Chief Scientific Officer at IONIS PHARMACEUTICALS INC (IONS), sold 20,000 shares at $43.98 ($880K) on 2025-08-18, disclosed to the SEC on 2025-08-20.
Scheduled sale ($880k) by EVP, Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.98 | 10,000 | $440K | 50.0% |
| 2 | $43.98 | 10,000 | $440K | 50.0% |
| Total | $43.98 avg | 20,000 | $880K | 100% |
| Filing → |
| IONS | SELL | 2026-02-04 | $14.1M | — | Filing → |
| IONS | SELL | 2026-02-02 | $976K | — | Filing → |
| IONS | SELL | 2026-01-20 | $675K | — | Filing → |